Douglas, Timothy Edward Lim and Schietse, Josefien and Zima, Aneta and Gorodzha, Svetlana and Parakhonskiy, Bogdan and Khalenkow, Dmitry and Shkarin, Roman and Ivanova, Anna and Baumbach, Tilo and Weinhardt, Venera and Stevens, Christian and Vanhoorne, Valerie and Vervaet, Chris and Balcaen, Lieve and Vanhaecke, Frank and Slosarczyk, Anna and Surmeneva, Maria and Surmenev, Roman and Skirtach, Andre (2018) Novel self-gelling injectable hydrogel/alpha-tricalcium phosphate composites for bone regeneration : Physiochemical and microcomputer tomographical characterization. Journal of Biomedical Materials Research Part A, 106 (3). pp. 822-828. ISSN 1549-3296
s1_ln27853020208917248_1939656818Hwf961360200IdV178746460027853020PDF_HI0001.pdf - Accepted Version
Available under License Creative Commons Attribution-NonCommercial.
Download (1MB)
Abstract
Mineralized hydrogels are increasingly gaining attention as biomaterials for bone regeneration. The most common mineralization strategy has been addition of preformed inorganic particles during hydrogel formation. This maintains injectability. One common form of bone cement is formed by mixing particles of the highly reactive calcium phosphate alpha-tricalcium phosphate (α-TCP) with water to form hydroxyapatite (HA). The calcium ions released during this reaction can be exploited to crosslink anionic, calcium-binding polymers such as the polysaccharide gellan gum (GG) to induce hydrogel formation. In this study, three different amounts of α-TCP particles were added to GG polymer solution to generate novel, injectable hydrogel-inorganic composites. Distribution of the inorganic phase in the hydrogel was studied by high resolution microcomputer tomography (µCT). Gelation occurred within 30 min. α-TCP converted to HA. µCT revealed inhomogeneous distribution of the inorganic phase in the composites. These results demonstrate the potential of the composites as alternatives to traditional α-TCP bone cement and pave the way for incorporation of biologically active substances and in vitro and in vivo testing.